pembrolizumab
merck
['key,note,716', 'keynote-716']
coming up this afternoon immunologist presents on the final analysis of the phase 3 keynote-716 study. abstract lba9505. hall d starting at 3 pm ct. 
NCI-designated Comprehensive Cancer Center and a global leader in cancer research and cancer care affiliated with @PittTweet